166 related articles for article (PubMed ID: 16217072)
1. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract][Full Text] [Related]
2. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Groves MD
Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241
[No Abstract] [Full Text] [Related]
3. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases.
Brandsma D; Taphoorn MJ; de Jager W; Bonfrer H; Algra A; Reijneveld JC; Boogerd W; Korse T; Verbeek MM; Rijkers GT; Voest EE
Neurology; 2006 Jan; 66(2):243-6. PubMed ID: 16434663
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.
Herrlinger U; Wiendl H; Renninger M; Förschler H; Dichgans J; Weller M
Br J Cancer; 2004 Jul; 91(2):219-24. PubMed ID: 15213721
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Offersen BV; Pfeiffer P; Andreasen P; Overgaard J
Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889
[TBL] [Abstract][Full Text] [Related]
7. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
9. [Vascular endothelial growth factor and plasminogen activators in endometrial carcinoma and hyperplasia].
Gerstein ES; Gritsaenko EV; Shcherbakov ME; Shcherbakov AM; Ognerudov NA; Kushlinskiĭ NE
Vopr Onkol; 2003; 49(6):725-9. PubMed ID: 14976916
[TBL] [Abstract][Full Text] [Related]
10. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of leptomeningeal metastases to the spine.
Chua SL; Goh PS; Tan LK
Singapore Med J; 1993 Jun; 34(3):253-6. PubMed ID: 8266185
[TBL] [Abstract][Full Text] [Related]
12. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon.
Logan-Collins JM; Lowy AM; Robinson-Smith TM; Kumar S; Sussman JJ; James LE; Ahmad SA
Ann Surg Oncol; 2008 Mar; 15(3):738-44. PubMed ID: 18043973
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of sialic acid in the CSF; in relation to the malignancy and leptomeningeal dissemination].
Moroki K; Kuratsu J; Yoshioka S; Kohchi M; Uemura S; Matsukado Y; Ushio Y
No To Shinkei; 1989 Mar; 41(3):305-7. PubMed ID: 2757844
[TBL] [Abstract][Full Text] [Related]
14. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
Shariat SF; Roehrborn CG; McConnell JD; Park S; Alam N; Wheeler TM; Slawin KM
J Clin Oncol; 2007 Feb; 25(4):349-55. PubMed ID: 17264329
[TBL] [Abstract][Full Text] [Related]
15. Spinal leptomeningeal metastases from prostate cancer.
Deinsberger R; Regatschnig R; Kaiser B; Bankl HC
Acta Neurochir (Wien); 2006 Apr; 148(4):467-71. PubMed ID: 16322903
[TBL] [Abstract][Full Text] [Related]
16. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG
Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
20. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
